A number of investment brokers have recently updated their price targets on shares of Achaogen, Inc. (AKAO). According to the latest broker reports outstanding on Monday 9th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

03/31/2016 – Achaogen, Inc. was downgraded to “market perform” by analysts at Cowen.

03/16/2016 – Achaogen, Inc. had its “neutral” rating reiterated by analysts at Wedbush. They now have a USD 7 price target on the stock.

03/16/2016 – Achaogen, Inc. was downgraded to “hold” by analysts at Needham & Company.

08/10/2015 – Achaogen, Inc. had its “buy” rating reiterated by analysts at Cantor Fitzgerald. They now have a USD 13 price target on the stock.

04/30/2015 – Achaogen, Inc. had its “buy” rating reiterated by analysts at Zacks. They now have a USD 10.9 price target on the stock.

03/02/2015 – Achaogen, Inc. was downgraded to “underperform” by analysts at Credit Suisse.

11/04/2014 – SunTrust began new coverage on Achaogen, Inc. giving the company a “buy” rating. They now have a USD 22 price target on the stock.

09/19/2014 – Achaogen, Inc. was upgraded to “buy” by analysts at Gabelli. They now have a USD 19 price target on the stock.

The share price of Achaogen, Inc. (AKAO) was down -1.29% during the last day of trading, with a day high of 3.21. 118363 shares were traded during the last session.

The stock’s 50 day moving average is 3.25 and its 200 day moving average is 4.45. The stock’s market capitalization is 56.17M. Achaogen, Inc. has a 52-week low of 2.59 and a 52-week high of 7.74.

View other investors thoughts on Achaogen, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.